Cellebrite Di Ltd (CLBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 475,675 | 401,203 | 325,110 | 270,651 | 246,246 |
| Cost of Goods | 75,172 | 62,593 | 53,231 | 50,746 | 42,557 |
| Gross Profit | 400,503 | 338,610 | 271,879 | 219,905 | 203,689 |
| Operating Expenses | 334,195 | 282,297 | 238,873 | 219,607 | 190,424 |
| Operating Income | 66,480 | 56,906 | 33,237 | 1,044 | 13,822 |
| Other Income | 24,198 | -332,890 | -108,800 | 119,716 | 68,483 |
| Pre-tax Income | 90,678 | -275,984 | -75,563 | 120,760 | 82,305 |
| Income Tax | 12,352 | 7,023 | 5,537 | -45 | 10,909 |
| Net Income Continuous | 78,326 | -283,007 | -81,100 | 120,805 | 71,396 |
| Net Income | $78,326 | $-283,007 | $-81,100 | $120,805 | $71,396 |
| EPS Basic Total Ops | 0.32 | -1.35 | -0.43 | 0.64 | 0.49 |
| EPS Basic Continuous Ops | 0.32 | -1.35 | -0.43 | 0.66 | 0.50 |
| EPS Diluted Total Ops | 0.31 | -1.35 | -0.43 | 0.59 | 0.44 |
| EPS Diluted Continuous Ops | 0.31 | -1.35 | -0.43 | 0.62 | 0.44 |
| EPS Diluted Before Non-Recurring Items | 0.35 | 0.30 | 0.18 | 0.03 | 0.20 |
| EBITDA(a) | $75,976 | $64,609 | $42,142 | $9,866 | $20,829 |